Prot #SD-809-C-20: AN OPEN-LABEL, LONG-TERM SAFETY STUDY OF SD-809 (DUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA

Project: Research project

Project Details

StatusFinished
Effective start/end date3/2/15 → 12/31/20

Funding

  • INNO Clinical Outcomes, LLC (Prot #SD-809-20 // Prot #SD-809-20)
  • Auspex Pharmaceuticals, Inc. (Prot #SD-809-20 // Prot #SD-809-20)